Could your pain be related to Rheumatoid Arthritis?

Learn about the signs and symptoms of Rheumatoid Arthritis and the options available for treatment.

Learn More

Having trouble identifying pills? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web’s most comprehensive Pill Identification Wizard.

Get Started

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Get Started

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Remember to take your pills with the Pill Reminder App?

Get pill and script reminders on your iPhone. Flexible scheduling options plus additional information on drug usage, side effects, interactions and more.

Learn More

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Welcome to Drugs.com

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products. Find helpful tools, wallet size personal medication records, mobile applications and more.

Featured Services
A to Z Drug List
Drugs by Condition
Pill Identifier
Drug Side Effects
Drug Dosage
Interactions Checker
News & Articles
FDA Drug Alerts
New Drug Approvals
New Drug Applications
Drug Imprint Codes
International Drugs
Drugs by Category
Pregnancy Warnings
Inactive Ingredients
 Medical Conferences
Health Guides
Symptom Checker
FDA Consumer Updates Medication Record
Clinical Trial Results
Medical Encyclopedia
Medical Dictionary
Patient Care Notes
For Professionals
Generic Drugs
Veterinary Drugs
Info en Español
Pill Identifier App (itunes)
Pill Reminder App (itunes)
Top 100 Drugs
Top 200 by sales
Abilify
Accutane
Actiq
Actonel
Adderall
Adipex
Advair
Allegra
Alli
Ambien
Amitiza
Aricept
Avandia
Avodart
Boniva
Botox
Byetta
Caduet
Celebrex
Celexa
Chantix
Cialis
Ciprofloxacin
Claritin
Clomid
Coumadin
Crestor
cyclobenzaprine
Cymbalta
Dilaudid
Diovan
Effexor
Enbrel
ephedrine
Femara
fish oil
Flomax
folic acid
Fosamax
gabapentin
Gardasil
Geodon
 Hoodia
Humira
hydrocodone
Insulin
Keppra
Lamictal
Lasix
Levaquin
Levitra
Lexapro
Lipitor
lisinopril
lithium
Lotrel
Lunesta
Lyrica
Melatonin
metformin
methadone
methotrexate
Mirapex
Mirena
Namenda
naproxen
Nasonex
Neurontin
Nexium
Nizoral
Norco
Norvasc
omeprazole
Ortho Evra
oseltamivir
oxycodone
oxycontin
Paxil
Paracetamol
Percocet
phentermine
Plan B
Plavix
prednisone
 Prevacid
Prilosec
promethazine
Propecia
Protonix
Provigil
Prozac
Pulmicort
Rogaine
Seroquel
sertraline
simvastatin
Singulair
Soma
Spiriva
Suboxone
Synvisc
Tamiflu
tamoxifen
Taxol
testosterone
thyroid
Topamax
tramadol
trazodone
Tylenol
Ultram
Valtrex
Viagra
Vicodin
Vioxx
Voltaren
Vytorin
Wellbutrin
Xanax
Xenical
Yasmin
Zetia
Zocor
Zoloft
Zyprexa
Zyrtec
More A-K · More L-Z · By Class · UK Medicines
For Consumers For Professionals For Researchers Announcements
Latest FDA New Drug Approvals

Sklice
Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in patients 6 months of age and ...

Jentadueto
Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide combination product indicated as an ...

Kalydeco
Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated for the treatment of cystic ...

More...

Drugs in Development – Not yet approved

lorcaserin
Lorcaserin is a selective serotonin 2C receptor agonist in development for weight management, including weight loss and maintenance of ...

Gattex
Gattex (teduglutide) is a novel, recombinant analog of human glucagon-like peptide 2 in development for the treatment of adults with short ...

bosutinib
Bosutinib is an oral, once-daily, investigational dual Src and Abl kinase inhibitor in development for the treatment of Philadelphia ...

More...

Daily Medical News

RSS
Heart Failure, Osteoporosis Go 'Hand-in-Hand': Researchers
TUESDAY, Feb. 7 -- Heart failure is linked to thinning of the bones and an increased risk of fractures, a new study indicates. The findings suggest that aggressive screening for osteoporosis may be important for heart failure patients, the researchers said. They looked at data from about 45,500 adults who underwent bone mineral density testing for the first time and were followed for up to 10...
New Meningitis Vaccine Works in Infants: Study
TUESDAY, Feb. 7 -- Routinely giving infants a new vaccine that guards against meningitis appears to be effective, a new study indicates. The multi-center clinical trial of almost 1,900 infants found that administration of routine infant immunizations with a vaccine for serogroup B Neisseria meningitidis -- a bacterium that can cause serious disease such as sepsis and meningitis -- was effective...
Kids' Diarrhea Vaccine Appears Safe After All: Study
TUESDAY, Feb. 7 -- Despite earlier research that suggested the rotavirus vaccine increased the risk of intussusception -- when a portion of the intestine slides forward into itself -- a large new study finds this is not the case. "The findings of our study are reassuring and add to the evidence that the benefits of rotavirus vaccine, in terms of reducing doctor's visits hospitalizations and...

More...

Latest Pharma Industry News

RSS
Sanofi Announces FDA Approval of Sklice Lotion for the Treatment of Head Lice
BRIDGEWATER, N.J., Feb. 7, 2012 /PRNewswire/ -- Sanofi announced today that the U.S. Food and Drug Administration (FDA) has approved Sklice (ivermectin) lotion, 0.5% for the topical treatment of head lice, in patients 6 months of age and older. Effective and well-tolerated, Sklice Lotion treats lice in most patients with a single 10-minute application of the lotion, without...
FDA Approves Jentadueto (linagliptin/metformin hydrochloride) for the Treatment of Adult Patients with Type 2 Diabetes
RIDGEFIELD, Conn., and INDIANAPOLIS, Jan. 30, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) has approved Jentadueto (linagliptin/metformin hydrochloride) tablets, a new tablet combining the dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, and metformin. Jentadueto provides a...
Edarbyclor (azilsartan medoxomil and chlorthalidone) Now Available in U.S. Pharmacies for Patients with Hypertension
DEERFIELD, Ill., February 6, 2012 and Osaka, Japan, February 7, 2012 – Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced EDARBYCLOR (azilsartan medoxomil and chlorthalidone) is now available by prescription in U.S. pharmacies for the treatment of hypertension to lower blood pressure in adults. It is the...

More...

Latest Additions to Drugs.com

Recently added consumer and prescribing information: Jentadueto, Kalydeco, Voraxaze, Erivedge, Bydureon, Inlyta, Picato, Zetonna, Subsys, Edarbyclor ...also see new filings.
Introducing the new Drugs.com Pill Reminder App for iPhone and iPod Touch
Drugs.com is proud to announce the release of a flexible and easy-to-use Pill Reminder and Personal Medication Record (PMR) app for your iPhone or iPod touch. Use this application to manage any combination of medications, vitamins/supplements and birth control pills. The intuitive interface lets you build a list of medications and setup reminders with ease ...
Drugs.com Pill Identifier Lite mobile app is now the #1 paid medical application in the Apple app store
1st June, 2011 – We are pleased to announce the Pill Identifier Lite mobile application has become the #1 paid medical app in the U.S. Apple App store. Thanks to all those who have downloaded the app. We look forward to providing regular updates and improvements. Please check out our apps page to get more ...
Pill Identifier Update
We’ve updated our pill identifier tool to help identify imprints that have been entered upside down and with similar letters. For example the imprint for Divalproex Sodium Extended-Release is 691: This could be read as 169 if the pill was held upside down. The pill identifier now recognizes imprints like this and will suggest an ...
See more blog posts or follow us on twitter.

(web1)